|
C13ORF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.187430E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.662020E-01 |
| Normal-vs-Stage2 |
4.816000E-01 |
| Normal-vs-Stage3 |
5.200100E-02 |
| Normal-vs-Stage4 |
1.601800E-01 |
| Stage1-vs-Stage2 |
6.770200E-01 |
| Stage1-vs-Stage3 |
3.488800E-01 |
| Stage1-vs-Stage4 |
8.332000E-01 |
| Stage2-vs-Stage3 |
3.262800E-01 |
| Stage2-vs-Stage4 |
6.282600E-01 |
| Stage3-vs-Stage4 |
6.055600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.231800E-02 |
| Normal-vs-AfricanAmerican |
8.095800E-01 |
| Normal-vs-Asian |
3.011400E-01 |
| Caucasian-vs-AfricanAmerican |
1.044220E-01 |
| Caucasian-vs-Asian |
6.061200E-01 |
| AfricanAmerican-vs-Asian |
3.278400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.516100E-03 |
| Normal-vs-Female |
2.902600E-01 |
| Male-vs-Female |
1.318400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.188600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.537820E-01 |
| Normal-vs-Age(61-80Yrs) |
4.253900E-02 |
| Normal-vs-Age(81-100Yrs) |
3.067600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.205600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.786810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.461700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.335200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.411790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.081600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.442000E-01 |
| Classical-VS-Follicular |
5.267600E-01 |
| Classical-VS-Other |
2.947200E-01 |
| Classical-VS-Normal |
2.496800E-01 |
| Tall-VS-Follicular |
4.614800E-01 |
| Tall-VS-Other |
2.263800E-01 |
| Tall-VS-Normal |
6.910200E-01 |
| Follicular-VS-Other |
4.633200E-01 |
| Follicular-VS-Normal |
1.775170E-01 |
| Other-VS-Normal |
1.358030E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.177600E-02 |
| Normal-vs-N1 |
4.744400E-02 |
| N0-vs-N1 |
8.053200E-01 |
|
|
